HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ravi C Balijepalli Selected Research

Caveolin 3

1/2019Long QT syndrome caveolin-3 mutations differentially modulate Kv 4 and Cav 1.2 channels to contribute to action potential prolongation.
9/2015Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
8/2013Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A.
5/2011Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.
10/2008Caveolae, ion channels and cardiac arrhythmias.
11/2006Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ravi C Balijepalli Research Topics

Disease

8Long QT Syndrome
01/2019 - 09/2003
4Heart Failure
05/2011 - 07/2003
3Cardiac Arrhythmias (Arrythmia)
01/2019 - 10/2008
3Cardiomegaly (Heart Hypertrophy)
09/2015 - 11/2003
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2012 - 07/2003
1Cardiovascular Diseases (Cardiovascular Disease)
11/2021
1Ventricular Premature Complexes (Premature Ventricular Contraction)
03/2016
1Cardiomyopathies (Cardiomyopathy)
03/2016
1Sudden Infant Death (SID)
08/2013
1congenital stationary Night blindness
05/2013
1Colonic Neoplasms (Colon Cancer)
11/2012
1Hypertrophy
05/2011
1Heart Diseases (Heart Disease)
10/2008
1Channelopathies
11/2006
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2003
1Tachycardia (Tachyarrhythmias)
07/2003

Drug/Important Bio-Agent (IBA)

6Caveolin 3IBA
01/2019 - 11/2006
5Proteins (Proteins, Gene)FDA Link
01/2019 - 07/2003
4Ether (Diethyl Ether)IBA
12/2012 - 09/2003
2SodiumIBA
11/2016 - 11/2006
2Ion Channels (Ion Channel)IBA
03/2016 - 10/2008
2CaveolinsIBA
11/2012 - 05/2011
1Biological ProductsIBA
11/2021
1Biomarkers (Surrogate Marker)IBA
11/2021
1Polyvinyl Chloride (PVC)IBA
03/2016
1Protein Kinase CIBA
09/2015
1CalcineurinIBA
09/2015
1Protein Kinases (Protein Kinase)IBA
09/2015
1Angiotensin IIIBA
09/2015
1Calcium Channels (Calcium Channel)IBA
05/2013
1Leucine (L-Leucine)FDA Link
01/2012
1Natriuretic PeptidesIBA
05/2011
1AnkyrinsIBA
11/2006
1beta Adrenergic ReceptorsIBA
09/2005
1Adrenergic Agents (Adrenergic Drugs)IBA
09/2005
1Endothelin-1 (Endothelin 1)IBA
11/2003
1Coloring Agents (Dyes)IBA
07/2003

Therapy/Procedure

1Therapeutics
11/2016